3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
23 24 0 0 0 0 0 0 0999 V2000
3.2449 0.2143 0.4422 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6578 2.1038 -0.2282 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7218 -1.7889 -0.5936 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5868 1.6317 -0.1118 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9881 0.2323 0.0977 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3329 -0.6674 0.0291 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6258 0.6939 -0.0235 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0504 -0.1847 -0.0928 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0658 -1.0916 -0.0087 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7493 1.2789 -0.1506 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3804 -1.5813 0.1167 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9518 1.0954 0.0131 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4223 -0.7036 -0.1242 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6752 -1.0833 0.1474 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6286 -0.1495 0.4869 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2622 -2.1583 0.0400 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.8332 2.6167 -0.1486 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.2045 -2.6511 0.1605 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.2317 2.1433 -0.0251 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.5247 -1.7553 0.2151 H 0 0 0 0 0 0 0 0 0 0 0 0
5.1793 0.6666 0.9621 H 0 0 0 0 0 0 0 0 0 0 0 0
5.0156 -0.2913 -0.5267 H 0 0 0 0 0 0 0 0 0 0 0 0
4.7623 -1.0576 1.0825 H 0 0 0 0 0 0 0 0 0 0 0 0
1 13 1 0 0 0 0
1 15 1 0 0 0 0
2 10 2 0 0 0 0
3 13 2 0 0 0 0
4 7 1 0 0 0 0
4 10 1 0 0 0 0
4 17 1 0 0 0 0
5 12 2 0 0 0 0
5 14 1 0 0 0 0
6 7 2 0 0 0 0
6 9 1 0 0 0 0
6 11 1 0 0 0 0
7 12 1 0 0 0 0
8 9 2 0 0 0 0
8 10 1 0 0 0 0
8 13 1 0 0 0 0
9 16 1 0 0 0 0
11 14 2 0 0 0 0
11 18 1 0 0 0 0
12 19 1 0 0 0 0
14 20 1 0 0 0 0
15 21 1 0 0 0 0
15 22 1 0 0 0 0
15 23 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
methyl 2-oxo-1H-1,7-naphthyridine-3-carboxylate
4.2 InChl
InChI=1S/C10H8N2O3/c1-15-10(14)7-4-6-2-3-11-5-8(6)12-9(7)13/h2-5H,1H3,(H,12,13)
4.3 InChlKey
IBMIAKGHPSCWCZ-UHFFFAOYSA-N
4.4 Canonical SMILES
COC(=O)C1=CC2=C(C=NC=C2)NC1=O
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病